(NASDAQ: ANIK) Anika Therapeutics's forecast annual revenue growth rate of 3.15% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.24%.
Anika Therapeutics's revenue in 2024 is $169,261,000.On average, 1 Wall Street analysts forecast ANIK's revenue for 2024 to be $2,521,089,604, with the lowest ANIK revenue forecast at $2,521,089,604, and the highest ANIK revenue forecast at $2,521,089,604. On average, 1 Wall Street analysts forecast ANIK's revenue for 2025 to be $2,659,706,010, with the lowest ANIK revenue forecast at $2,659,706,010, and the highest ANIK revenue forecast at $2,659,706,010.
In 2026, ANIK is forecast to generate $2,830,959,849 in revenue, with the lowest revenue forecast at $2,830,959,849 and the highest revenue forecast at $2,830,959,849.